IDEXX Laboratories Aktie
WKN: 888210 / ISIN: US45168D1046
02.02.2021 12:46:06
|
IDEXX Laboratories Sees FY21 Earnings, Revenue Above Estimates - Quick Facts
(RTTNews) - While reporting its financial results for the fourth quarter on Tuesday, IDEXX Laboratories Inc. (IDXX) provided its financial outlook for fiscal 2021 above analysts' expectations.
The company forecast fiscal 2021 earnings of $7.39 to $7.71 per share, an increase of 10 percent to 14 percent as reported and 15 percent to 20 percent on a comparable constant currency basis. The company also provided initial outlook for fiscal 2021 revenue of $3.065 billion to $3.120 billion, reflecting reported growth of 13 percent to 15.5 percent and organic growth of 11.5 percent to 13.5 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $6.81 per share for the year on revenue growth of 10.9 percent to $2.96 billion. Analysts' estimates typically exclude special items.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
IDEXX Laboratories | 355,30 | 1,63% |
|